Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-05

Clinical Trial Update: Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia

View source ↗

Summary

A completed clinical trial evaluating the effects of nicotine on areas of impaired and preserved functioning in individuals with schizophrenia and nicotine depe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine (nicotine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Nicotine Dependence, Schizophrenia | Status: COMPLETED